The Smart Investor
    Facebook Instagram
    Tuesday, July 28
    Facebook Instagram LinkedIn
    The Smart Investor
    • Home
    • About
      • About Us
      • Careers
    • Smart Investing
      • Getting Started
      • Investing Strategy
      • Smart Analysis
      • Smart Reads
    • US Stocks
    • Special Free Reports!
    • As Featured on BT
    • Our Services
      • Our Services
      • Subscribe now!
    • Login
    • Cart
    The Smart Investor
    Home»Dividend Stocks»4 Singapore Stocks That Can Maintain or Increase Their Dividends Despite Trump’s Tariffs
    Dividend Stocks

    4 Singapore Stocks That Can Maintain or Increase Their Dividends Despite Trump’s Tariffs

    These companies can hold their own when it comes to dividends despite macroeconomic concerns.
    Royston Y.By Royston Y.April 16, 20255 Mins Read
    Facebook Twitter LinkedIn Email WhatsApp
    The Hour Glass (TSI photo by Royston Yang)
    Image credit: The Smart Investor
    Share
    Facebook Twitter LinkedIn Email WhatsApp

    Trump’s recent shock tariff announcement is expected to result in a wave of price increases as companies absorb these higher costs.

    Naturally, investors are worried about businesses deferring their expansion plans amid a slump in consumer demand as people fret about higher prices.

    However, some businesses remain resilient to these tariffs as they have a strong business model or sustainable catalysts that can allow them to withstand these headwinds.

    Income investors should also rest assured that these stocks can at least maintain, or may even increase their dividends.

    Here are four stocks that fit this bill that you may wish to add to your buy watchlist.

    The Hour Glass (SGX: AGS)

    The Hour Glass, or THG, is a leading specialist watch retailer with 65 boutiques across 14 cities.

    The group features famous Swiss watch brands such as Rolex, Hublot, Chopard, Patek Philippe, and Cartier in its portfolio.

    THG derives its revenue principally from Southeast Asia and North Asia, hence the business should be relatively insulated from the tariffs.

    Moreover, the luxury timepiece industry is also less sensitive to price increases as most of these watches have a high price tag.

    For the first half of fiscal 2025 (1H FY2025) ending 30 September 2024, THG saw total revenue dip 3% year on year to S$548.8 million.

    The fall was because of a moderation in demand from the end of the pandemic.

    Net profit for 1H FY2025 fell 20% year on year to S$61.4 million.

    Despite the lower profits, THG continued to churn out a healthy free cash flow of S$39.4 million, just 2% lower than the S$40.1 million generated in 1H FY2024.

    The luxury watch retailer kept its interim dividend constant at S$0.02 per share.

    Earlier this month, THG purchased an Australian company, SPV, for around A$90 million, to expand its presence in Australia and strengthen the group’s retail footprint.

    iFAST Corporation (SGX: AIY)

    iFAST is a financial technology company operating a platform for the buying and selling of unit trusts, equities, and bonds.

    The group reported a sterling set of earnings for 2024 as it enjoyed net inflows of S$3.3 billion for the year, pushing its assets under administration (AUA) to a new record of S$25.01 billion as of 31 December 2024.

    Net revenue for last year rose 53.6% year on year to S$248.4 million while operating profit more than doubled year on year to S$84.6 million, driven by strong contributions from the group’s Hong Kong ePension contract.

    Net profit stood at S$66.6 million for 2024, 136% higher than the S$28.3 million recorded for 2023.

    The fintech raised its total 2024 dividend to S$0.059, 23% higher than the S$0.048 paid out a year ago.

    Looking ahead, the group expects to enjoy further progress in its various business divisions.

    Management expects iFAST’s AUA to continue posting healthy growth, which will drive improvements in revenue and profitability.

    The Hong Kong ePension division should also see more growth as onboarding rates continue, and the group expects to enjoy robust growth in profitability.

    With higher profits, there is also a good chance that iFAST can continue to raise its dividends.

    Singapore Technologies Engineering (SGX: S63)

    Singapore Technologies Engineering, or STE, is a technology, defence and engineering group serving customers in the aerospace, smart city, defence, and public security sectors.

    The blue-chip group reported a strong set of earnings for 2024 with revenue rising 11.6% year on year to S$11.3 billion.

    Operating profit climbed 17.7% year on year to S$1.1 billion while net profit shot up 20% year on year to S$702.3 million.

    In line with the good results, STE raised its final dividend from S$0.04 last year to S$0.05, culminating in a total 2024 dividend of S$0.17, up one cent from S$0.16 a year ago.

    The engineering giant snagged a total of S$12.6 billion in new contracts last year, which pushed its order book to S$28.5 billion as of 31 December 2024.

    STE shared its strategic plans and goals during its recent Investor Day 2025.

    The group intends to steadily increase its revenue over the next five years while adopting a progressive dividend policy.

    For 2025, STE anticipates paying out a total dividend of S$0.18, one cent above 2024’s dividend.

    From 2026 onwards, the group plans to pay out around one-third of its year-on-year increase in net profit as incremental dividends.

    Raffles Medical Group (SGX: BSL)

    Raffles Medical Group, or RMG, is an integrated healthcare player operating in 14 cities within five countries.

    The group’s network includes four hospitals and over 100 multi-disciplinary clinics offering a broad range of healthcare and health screening services.

    RMG reported a mixed set of earnings for 2024 as its COVID-19 boost tailed off.

    Revenue rose 6.3% year on year to S$751.6 million but operating profit tumbled 28.7% year on year to S$82.5 million.

    Net profit plunged 31% year on year to S$62.2 million.

    The integrated healthcare player also generated a positive free cash flow of S$65.3 million for 2024.

    Despite the fall in net profit, RMG declared a slightly higher final dividend of S$0.025, up from S$0.024 last year.

    For 2025, the group plans to embrace automation to boost its efficiency.

    RMG significantly upgraded its laboratory capabilities by implementing a custom-built laboratory information system.

    CEO Dr Loo Choon Yong also expects the group’s China hospitals to break even in one to two years, which would be another positive catalyst for the business.

    Big Tech is spending hundreds of billions on AI,  and the ripple effects are just beginning. Our new investor guide shows how AI is changing the way companies generate revenue, structure their business models, and gain an edge. Even if you already know the major players, this report reveals something far MORE important: The why and how behind their moves, and what it means for your portfolio. Download your free report now.

    Follow us on Facebook and Telegram for the latest investing news and analyses!

    Disclosure: Royston Yang owns shares of iFAST Corporation and Raffles Medical Group.

    Yahoo
    Share. Facebook Twitter LinkedIn Email WhatsApp

    Related Posts

    Keppel

    Keppel Corporation: Why Analysts Are Overlooking Its Deep Value

    July 28, 2026
    Seatrium

    3 Temasek-Backed Singapore Stocks Reporting This Week

    July 28, 2026
    digital core reit

    Beyond STI: 3 REITs Declaring their Latest DPU This Week

    July 28, 2026
    Facebook Instagram LinkedIn Telegram
    • Careers
    • Disclaimer & Privacy Policy
    • Advertising & Media Enquiries
    • Subscription Terms of Service
    © 2026 The Smart Investor. All Rights Reserved. The Smart Investor, thesmartinvestor.com.sg, an investment education website managed by The Investing Hustle Pte Ltd (Company Reg No. 201933459Z) is not licensed or otherwise regulated by the Monetary Authority of Singapore, and in particular, is not licensed or regulated to carry on business in providing any financial advisory service. Accordingly, any information provided on this site is meant purely for informational and investor educational purposes and should not be relied upon as financial advice. No information is presented with the intention to induce any reader to buy, sell, or hold a particular investment product or class of investment products. Rather, the information is presented for the purpose and intentions of educating readers on matters relating to financial literacy and investor education. Accordingly, any statement of opinion on this site is wholly generic and not tailored to take into account the personal needs and unique circumstances of any reader. The Smart Investor does not recommend any particular course of action in relation to any investment product or class of investment products. Readers are encouraged to exercise their own judgment and have regard to their own personal needs and circumstances before making any investment decision, and not rely on any statement of opinion that may be found on this site.

    Type above and press Enter to search. Press Esc to cancel.